Abi Race: A prospective, multicenter study of black (B) and white (W) patients (pts) with metastatic castrate resistant prostate cancer (mCRPC) treated with abiraterone acetate and prednisone (AAP).
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Daniel J. George, Elisabeth I. Heath, A. Oliver Sartor, Guru Sonpavde, William R. Berry, Patrick Healy, Carolyn Winters, Colleen Riggan, Monika Anand, Julie Kephart, Matthew I. Milowsky, Mark T. Fleming, K. C. Balaji, Tian Zhang, Rhonda L. Bitting, Michael Roger Harrison, Megan Ann McNamara, Jennifer A. Freedman, Susan Halabi, Andrew J. Armstrong, Deborah Bruner
Institutions: Duke University, Wayne State University, The Barbara Ann Karmanos Cancer Institute, Tulane University, Dana-Farber Cancer Institute, Duke Cancer Institute, University of North Carolina at Chapel Hill, Virginia Oncology Associates, Wake Forest University Health Sciences, Duke Medical Center, Winship Cancer Institute
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2805958911